Lacidipine
Antihypertensive drug of the calcium channel blocker class From Wikipedia, the free encyclopedia
Antihypertensive drug of the calcium channel blocker class From Wikipedia, the free encyclopedia
Lacidipine (tradenames Lacipil or Motens) is a calcium channel blocker. It is available as tablets containing 2 or 4 mg.
Clinical data | |
---|---|
Trade names | Lacipil, Motens |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | ~10% |
Protein binding | >95% |
Metabolism | Hepatic |
Onset of action | 30–50 min |
Elimination half-life | 13–19 hours |
Excretion | Feces (~70%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.166.373 |
Chemical and physical data | |
Formula | C26H33NO6 |
Molar mass | 455.551 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
It was patented in 1984 and approved for medical use in 1991.[1]
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.